DD
67
6
ALLE
37
-4
JCI
44
2
ILMN
23
-5
VLO
45
6
UHS
60
-3
C
48
-2
CB
57
3
XOM
54
3
BK
74
3
BRK.B
47
2
MPC
44
5
GT
49
-3
TSN
38
-2
AIG
66
4
NAVI
36
-2
SNA
60
2
CI
49
3
RCL
62
-3
CAT
69
3
DD
67
6
ALLE
37
-4
JCI
44
2
ILMN
23
-5
VLO
45
6
UHS
60
-3
C
48
-2
CB
57
3
XOM
54
3
BK
74
3
BRK.B
47
2
MPC
44
5
GT
49
-3
TSN
38
-2
AIG
66
4
NAVI
36
-2
SNA
60
2
CI
49
3
RCL
62
-3
CAT
69
3
Financhill
Back

Theravance Biopharma Vs. Fate Therapeutics Industry Stock Comparison

Sell
28

TBPH
Theravance Biopharma

Last Price:
9.26
Seasonality Move:
-7.26%
Sell
39

FATE
Fate Therapeutics

Last Price:
3.91
Seasonality Move:
9.33%
Sell
28
Theravance Biopharma (TBPH) is a Sell

Is Theravance Biopharma a Buy, Sell or Hold?

  • The current Theravance Biopharma [TBPH] share price is $9.29. The Score for TBPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • TBPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Fate Therapeutics (FATE) is a Sell

Is Fate Therapeutics a Buy, Sell or Hold?

  • The current Fate Therapeutics [FATE] share price is $3.90. The Score for FATE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • FATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBPH Stock Price Chart

What is Theravance Biopharma's stock price today?

  • The Theravance Biopharma share price today is $9.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.

FATE Stock Price Chart

What is Fate Therapeutics's stock price today?

  • The Fate Therapeutics share price today is $3.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.

TBPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 48.81 Sell
Chaikin Money Flow: -238819 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.05 - 9.67) Sell
Bollinger Bands (100): (8.64 - 10.1) Sell

FATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 34.28 Sell
Chaikin Money Flow: -1079883 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.81 - 4.85) Sell
Bollinger Bands (100): (4.25 - 7.09) Sell

TBPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.51 Sell
20-day SMA: 9.32 Sell
50-day SMA: 9.17 Buy
200-day SMA: 9.59 Sell
8-day EMA: 9.48 Sell
20-day EMA: 9.39 Sell
50-day EMA: 9.3 Sell
200-day EMA: 9.61 Sell

FATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.05 Sell
20-day SMA: 4.1 Sell
50-day SMA: 5.69 Sell
200-day SMA: 4.05 Sell
8-day EMA: 4.08 Sell
20-day EMA: 4.35 Sell
50-day EMA: 5.07 Sell
200-day EMA: 5.53 Sell

Theravance Biopharma Earnings Growth & TBPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.

Fate Therapeutics Earnings Growth & FATE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.10 per share, and an increase next year of $0.09 per share.

Theravance Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Fate Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):